Degroux Brugère advised Bpifrance and Kurma Partners, historical investors of Kiro, a company specialized in digital medicine, in its €13.8 million Series A financing round.
The round was led by Sofinnova Partners. The historical investors, the Ambition Amorçage Angels (F3A) fund of France 2030, managed on behalf of the French government by Bpifrance and Kurma Partners, also participated in the financing alongside Propulia Capital, entrepreneurs and European and American business angels.
Thanks to this investment, the Marseille-based start-up is now in a position to develop its artificial intelligence platform for interpreting medical examinations, and also to expand internationally.
This transaction was carried out by DEGROUX BRUGERE with Jérémie Swiecznik, partner.
The round was led by Sofinnova Partners. The historical investors, the Ambition Amorçage Angels (F3A) fund of France 2030, managed on behalf of the French government by Bpifrance and Kurma Partners, also participated in the financing alongside Propulia Capital, entrepreneurs and European and American business angels.
Thanks to this investment, the Marseille-based start-up is now in a position to develop its artificial intelligence platform for interpreting medical examinations, and also to expand internationally.
This transaction was carried out by DEGROUX BRUGERE with Jérémie Swiecznik, partner.